Records containing: IgA Nephropathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-06-05Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA)Nephropathy Course QUIgAN Study
-
CLINICAL_TRIALS study record update · 2025-04-20A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Clinical Activity of ADX-097 Administered Subcutaneously in Male and Female Participants Aged 18 Years or Older With IgAN, LN, or C3G
-
CLINICAL_TRIALS study record update · 2025-04-06A Phase 2b, Multicenter, Open-label, Single-arm Trial to Evaluate the Impact of Sibeprenlimab on Kidney Histopathology Through Repeat Kidney Biopsies in Adolescents and Adults With Immunoglobulin A Nephropathy
-
CLINICAL_TRIALS study record update · 2025-03-20A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of VIS649 Administered Intravenously in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-03-14A Multicentre, Randomized, Controlled Study of Rituximab in Treatment of Primary IgA Nephropathy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-12Correlation of Microbiome and Metabonomics With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-03-11A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-02-13A Phase 2 Study to Evaluate the Safety and Biologic Activity of APL- 2 in Patients With IgA Nephropathy, Lupus Nephritis, Primary Membranous Nephropathy, or C3 Glomerulopathy (C3 Glomerulonephritis and Dense Deposit Disease)
-
CLINICAL_TRIALS study record update · 2025-02-11Therapeutic Evaluation of STeroids in IgA Nephropathy Global - Post-Trial ObservatioNal Cohort Study
-
CLINICAL_TRIALS study record update · 2025-01-14A Randomized, Double-blind, Placebo-controlled Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SCTC21C in Subjects With Plasma Cell-driven Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-01-10A Single-Arm Open-Label Feasibility Study of Probiotics for the Modulation of the Gut Microbiome in IgA Nephropathy (Pro-IgAN)
-
CLINICAL_TRIALS study record update · 2025-01-07A Randomized, Double Blind, Placebo Parallel Controlled, 2 Cohorts, Multicenter Phase II Study to Investigate the Safety and Efficacy of SC0062 Capsule in Patients With Chronic Kidney Disease With Albuminuria
-
CLINICAL_TRIALS study record update · 2024-11-26Evaluation of IM19 CAR-T Cell Therapy for IgA Nephropathy With Urinary Protein and Renal Dysfunction Safety and Efficacy of Patients With Primary Membranous Nephropathy and Those at Medium to High Risk Clinical Research
-
CLINICAL_TRIALS study record update · 2024-10-15A Phase II Clinical Study Evaluating the Efficacy and Safety of CM338 Injection in Subjects With Immunoglobulin A Nephropathy
-
CLINICAL_TRIALS study record update · 2024-10-15A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
-
CLINICAL_TRIALS study record update · 2024-10-09A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Studyto Evaluate the Safety, Tolerability and Pharmacokinetics of HS-10390 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-08-30A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Finerenone in the Treatment of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2024-06-14Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA
-
CLINICAL_TRIALS study record update · 2024-06-04The Effect of Obstructive Sleep Apnea on Severity and Prognosis of Patients With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2024-05-28Construction of a Multi-center Database for Primary IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2024-03-26A Phase 2a, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2023-12-06A Phase 2, Randomized, Double-Blind, Multicenter Study of Telitacicept for Injection (RC18) With an Optional Open Label Extension in Subjects With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2023-12-06Registry of IgA Nephropathy in Chinese Children
-
CLINICAL_TRIALS study record update · 2023-10-04National Registry of Rare Kidney Diseases (RaDaR)
-
CLINICAL_TRIALS study record update · 2023-04-21A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy